Jiutian - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
08/24/20	Amfrasers	Jiutian	0.046	0.068	Outperform	PER8x
09/07/20	Amfrasers	Jiutian	0.05	0.068	Outperform
11/04/20	UOB Kay Hian	Jiutian	0.098	0.16	Buy	PER5x FY21
11/12/20	UOB Kay Hian	Jiutian	0.115	0.18	Buy	PER5x FY21
11/26/20	Amfrasers	Jiutian	0.086	0.14	Not Rated
01/18/21	CIMB	Jiutian	0.1	0.145	Add	PER5.7x FY22

Stock calls for 22 January 2021

Date	Analyst	Company	Last	Target	Call	Valuation
01/22/21	Kim Eng	Capitaland Integrated Commercial Trust	2.3	2.55	Buy
01/22/21	UOB Kay Hian	Capitaland Integrated Commercial Trust	2.3	2.32	Hold	Buy @ $2.12
01/22/21	CIMB	Capitaland Integrated Commercial Trust	2.3	2.56	Add
01/22/21	DMG & Partners	Capitaland Integrated Commercial Trust	2.3	2.1	Neutral
01/22/21	Lim & Tan	Sabana	0.375	0	Accumulate

More than 12K Israelis are getting re-inflected after getting Pfizer vaccinations.

https://www.globaltimes.cn/page/202101/1213566.shtml

Statistics in Israel are showing that Pfizer's efficacy is not as good as proclaimed.  As more vaccinated people get exposed to the virus, we will know the true efficacy in the foreseeable future.  The efficacy will drop further when the new variant infiltrates Israel.

Current vaccinations maybe ineffective against new covid variants.

https://www.cnbc.com/2021/01/21/dr-fauci-says-covid-vaccines-appear-to-be-less-effective-against-some-new-strains.html

Dr. Fauci has just announced his latest update about the efficacy of the existing vaccinations.  Furthermore, South Africa's NICD stated that the new variant was able to escape from our antibodies.

“Furthermore, 501Y.V2 shows substantial or complete escape from neutralising antibodies in COVID-19 convalescent plasma,” researchers with South Africa’s National Institute for Communicable Diseases wrote. Their conclusions, they said, “highlight the prospect of reinfection ... and may foreshadow reduced efficacy of current spike-based vaccines.”

Why did China clamp down on Ant's IPO? - Part 2

https://finance.yahoo.com/news/china-plans-online-payment-rules-105342219.html

Just as we've expected, Ant's valuation is seen falling by more than 50%.

We had given our assessment on Ant previously below.

http://sg-stock.blogspot.com/2020/11/why-did-china-clamp-down-on-ants-ipo.html

JEP - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/04/20	Phillip	JEP	0.205	0.25	Buy	PER14x FY20
08/21/20	Phillip	JEP	0.19	0.158	Reduce	PB1x
10/27/20	UOB Kay Hian	JEP	0.175	0.2	Buy

Jardine Matheson - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
03/10/20	CIMB	Jardine Matheson	50.12	52.53	Hold	Cut from $61.66
08/03/20	CIMB	Jardine Matheson	40.92	48.61	Add	PB0.78x FY20
12/02/20	CIMB	Jardine Matheson	54.52	54.68	Hold	PB0.85x

Japfa - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
01/20/20	UOB Kay Hian	Japfa	0.64	0.8	Buy
01/31/20	CIMB	Japfa	0.56	0.69	Add
01/31/20	Kim Eng	Japfa	0.56	0.72	Buy
03/03/20	UOB Kay Hian	Japfa	0.59	0.88	Buy	Sum of parts
03/04/20	DBS Vickers	Japfa	0.575	0.84	Buy	Sum of parts, PER11x
04/16/20	CIMB	Japfa	0.51	0.95	Add	PER12x CY21
04/16/20	UOB Kay Hian	Japfa	0.51	0.9	Buy	Sum of parts
04/16/20	DBS Vickers	Japfa	0.51	0.84	Buy
05/18/20	UOB Kay Hian	Japfa	0.635	0.98	Buy	Sum of parts
05/18/20	DBS Vickers	Japfa	0.635	0.86	Buy	Sum of parts, PER10x FY21
06/30/20	DBS Vickers	Japfa	0.67	0.82	Buy	Sum of parts, PER10.5x FY21
08/03/20	UOB Kay Hian	Japfa	0.66	0.98	Buy	Sum of parts
08/03/20	DBS Vickers	Japfa	0.66	0.82	Buy	Sum of parts
08/03/20	CIMB	Japfa	0.66	0.96	Add
10/13/20	CIMB	Japfa	0.65	0.96	Add
11/02/20	UOB Kay Hian	Japfa	0.645	0.98	Buy	Sum of parts
11/02/20	DBS Vickers	Japfa	0.645	1.03	Buy	sum of parts, PER11.3x FY21
12/08/20	UOB Kay Hian	Japfa	0.805	1	Buy	Sum of parts
12/08/20	DBS Vickers	Japfa	0.805	1.03	Buy	sum of parts, PER11.3x FY21
12/10/20	CIMB	Japfa	0.825	1	Add